Eli Lilly to expand US pharma manufacturing with 4 new sites

Eli Lilly to spend billions on new pharmaceutical manufacturing sites
Eli Lilly announced plans for four new pharmaceutical manufacturing sites to produce domestic medicine production in the United States and make the nation the world's leader in pharmaceutical production.
Eli Lilly says it will spend billions to move drug manufacturing to U.S. soil
Eli Lilly said it plans to build three new plants in the United States to make the key ingredients used in pharmaceuticals, part of a doubling of its investment in manufacturing.
Indy-based pharmaceutical giant Eli Lilly to invest roughly $27 billion in manufacturing
Pharmaceutical giant Eli Lilly announced Wednesday that it plans to invest roughly $27 billion in United States manufacturing more than doubling its investment over the past five years. The company said this will be the largest pharmaceutical manufacturing investment in United States history.
Eli Lilly will build 4 new manufacturing sites to increase domestic drug production
Eli Lilly and Co. is in negotiations with several states and plans to announce the locations of four new manufacturing plants later this year.
Eli Lilly announces $27 billion investment in U.S. drug manufacturing sites
Eli Lilly plans to spend $27 billion to build new drug manufacturing sites in the U.S., at a time when President Trump is seeking to press drugmakers to move stateside.
Eli Lilly Expands IN, NC, WI Sites, Invests $50B In U.S. Since 2020
The pharmaceutical firm is growing its presence across three states, creating 3,000 jobs.
Eli Lilly plans to more than double investment in US manufacturing
The Indianapolis-based pharmaceutical company announced plans for four new manufacturing sites, but has not decided where they will go.
Eli Lilly and Co. Plans to Build Four New Sites in the U.S.
Eli Lilly and Company said Wednesday they plan to build new pharmaceutical manufacturing sites in the United States.
Eli Lilly to spend $27B on four new manufacturing sites
Indianapolis-based pharmaceutical giant Eli Lilly and Co. announced plans Wednesday to add four new manufacturing sites in a roughly $27 billion investment expected to create 3,000 jobs and nearly 10,000 construction positions during the buildout.
Eli Lilly wants to make drugs in America. First it wants a tax cut
Eli Lilly (LLY), the maker of the blockbuster weight-loss drug Zepbound, announced Wednesday that it plans to invest $27 billion in four new manufacturing sites in the United States. But the company made it clear that those plans hinge on tax cuts.
Zepbound maker Eli Lilly announces $27 billion investment in US drug manufacturing as Trump threatens tariffs
Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional ...
Eli Lilly plans to invest $27B to build four new US plants as tariffs loom
Pharmaceutical giant expects the move will create 3,000 high-skilled jobs and provide work for approximately 10,000 ...
Yahoo Finance2d
Eli Lilly and Company (LLY)
Eli Lilly (LLY), the maker of the blockbuster weight-loss drug Zepbound, announced Wednesday that it plans to invest $27 billion in four new manufacturing sites in the United States. But the ...